- Home
- HOLX
HOLX
Hologic Inc.
as 08-27-2025 2:32pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 14.5B | IPO Year: | 1990 |
| Target Price: | $76.27 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.41 | EPS Growth: | -17.18 |
| 52 Week Low/High: | $51.90 - $84.39 | Next Earning Date: | 07-30-2025 |
| Revenue: | $4,038,900,000 | Revenue Growth: | 1.29% |
| Revenue Growth (this year): | 3.12% | Revenue Growth (next year): | 4.88% |
Latest Hologic Inc. News
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks
7 days ago
Here's Why Hologic (HOLX) is a Strong Value Stock
Zacks
7 days ago
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
Barchart
14 days ago
What Are Wall Street Analysts' Target Price for Hologic Stock?
Zacks
14 days ago
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
StockStory
15 days ago
Hologic’s Q2 Earnings Call: Our Top 5 Analyst Questions
StockStory
15 days ago
HOLX Q2 Deep Dive: Breast Health Turnaround and New Product Launches Drive Momentum
GlobeNewswire
15 days ago
STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories
Compare HOLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.